ArticleAmerican journal of hematology2023

Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era.

Fadi G Haddad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.